PHOENIX, May 15, 2023
/PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) (www.senestech.com)
the rodent fertility control experts and inventors of the only
EPA-registered contraceptive for male and female rats,
ContraPest®, today announced Joel Fruendt, CEO, will participate in a
fireside chat and host one-on-one meetings with investors at the
Lytham Partners Spring 2023 Investor Conference, taking place
virtually on May 18, 2023.
Company Webcast
The Company's webcasted fireside chat will be available for
viewing at 9:00am ET on Thursday, May 18,
2023, on the Company's website at
http://senestech.investorroom.com/ or
https://wsw.com/webcast/lytham8/snes/2055375. The webcast will also
be archived and available for replay.
1x1 Meetings
Management will be participating in virtual one-on-one meetings
throughout the event. To arrange a meeting with management, please
contact Lytham Partners at 1x1@lythampartners.com or register at
https://www.lythampartners.com/spring2023invreg/.
About SenesTech
We are "The Pest Control Difference" for the 21st century. We
are rodent fertility control specialists fueled by our passion to
create a healthy environment by virtually eliminating rodent pest
populations. We keep an inescapable truth in mind: 2 rats and their
descendants can be responsible for the birth of up to 15,000 pups
in a year. We invented ContraPest, the only U.S. EPA-registered
contraceptive for male and female rats. ContraPest fits seamlessly
into all integrated pest management programs, greatly improving the
overall goal of effective rat management. We strive for clean
cities, efficient businesses, and happy households – with a product
that was designed to be effective and sustainable without killing
rats. At SenesTech , we don't just eliminate rats. We make a better
world.
For more information visit https://senestech.com/ and
https://contrapeststore.com.
Safe Harbor
Statement
The foregoing paragraphs contain forward-looking statements
that involve estimates, assumptions, risks and uncertainties. Any
statements about our expectations, beliefs, plans, objectives,
assumptions or future events or performance are not historical
facts and may be forward-looking. "Forward-looking statements" may
be preceded by words such as "may," "future," "plan" or "planned,"
"will," "should," "expected," "anticipates," "continue,"
"eventually," "believes," or "projected." Forward-looking
statements include statements concerning the potential impact and
effects of the COVID-19 pandemic on the Company's business, results
of operations and financial performance; any measures the Company
has and may take in response to COVID-19 and any expectations the
Company may have with respect thereto; the Company's strategy and
target marketing and markets; continuing the Company's vision;
expected benefits of the Company's initiatives and continuation of
those initiatives; deployment of the Company's product; the
continuation or expansion of the use of ContraPest; demand for
ContraPest; the Company's expectation regarding costs, expenses and
cash and continuing its cost improvement plan; future financial
results; and the Company's execution of its strategic business
plan.
CONTACT:
Investor: Robert Blum, Lytham
Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief
Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download
multimedia:https://www.prnewswire.com/news-releases/senestech-to-participate-at-lytham-partners-spring-2023-investor-conference-on-may-18-2023-301824665.html
SOURCE SenesTech, Inc.